Population-level associations between antiretroviral therapy scale-up and all-cause mortality in South Africa

International Journal of STD and AIDS

Volumn 25, Issue 9, 2014, Pages 636-642

  Larson, Elysia ^a   Bendavid, Eran ^b   Tuoane Nkhasi, Maletela ^c   Mbengashe, Thobile ^d   Goldman, Thurma ^a   Wilson, Melinda ^e   Klausner, Jeffrey D ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Statistics South Africa   (South Africa)

^d National Department of Health   (South Africa)

^e US Agency for International Development   (South Africa)

Author keywords

Africa; AIDS; antiretroviral therapy; HIV; mortality decline; PEPFAR; treatment

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; CHILD; DEATH; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPULATION RESEARCH; PRIORITY JOURNAL; SOUTH AFRICA; AGE DISTRIBUTION; CAUSE OF DEATH; EPIDEMIOLOGY; HEALTH CARE DELIVERY; HEALTH CARE SURVEY; HEALTH SURVEY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV INFECTIONS; PROCEDURES; SEX RATIO; SUPPLY AND DISTRIBUTION; YOUNG ADULT;

ADULT; AGE DISTRIBUTION; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CAUSE OF DEATH; CHILD; FEMALE; HEALTH CARE SURVEYS; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HUMANS; MALE; MORTALITY; POPULATION SURVEILLANCE; SEX DISTRIBUTION; SOUTH AFRICA; YOUNG ADULT;

EID: 84905653107     PISSN: 09564624     EISSN: 17581052     Source Type: Journal    
DOI: 10.1177/0956462413515639     Document Type: Article

References (53)

1. Centers for Disease Control and Prevention. CDC fact sheet: HIV and AIDS among gay and bisexual men. Report, Atlanta, GA, 2011.
2. Lopez AD,Mathers CD,Ezzati M, et alGlobal burden of disease and risk factors. Washington, DC: Oxford University Press and The World Bank; 2006:1-475.
3. Beyrer C,Baral SD,Walker Det al.The expanding epidemics of HIV Type 1 among men who have sex with men in low- and middle-income countries: diversity and consistency.Epidemiol Rev. 2010;32:137-151.
4. Benotsch EG,Martin AM,Koester Set al.Nonmedical use of prescription drugs and HIV risk behavior in gay and bisexual men.Sex Transm Dis. 2011;38:105-110.
5. Colfax GN,Mansergh G,Guzman Ret al.Drug use and sexual risk behavior among gay and bisexual men who attend circuit parties: a venue-based comparison.J Acquir Immune Defic Syndr. 2001;28:373-379.
6. Colfax G,Coates TJ,Husnik MJet al.Longitudinal patterns of methamphetamine, popper (Amyl nitrite), and cocaine use and high-risk sexual behavior among a cohort of San Francisco men who have sex with men.J Urban Health. 2005;82:I62-I70.
7. Reback CJ,Shoptaw S,Grella CE.Methamphetamine use trends among street-recruited gay and bisexual males, from 1999 to 2007.J Urban Health. 2008;85:874-879.
8. Stall R,Paul JP,Greenwood Get al.Alcohol use, drug use and alcohol-related problems among men who have sex with men: the urban men's health study.Addiction. 2001;96:1589-1601.
9. Hickson F,Bonell CP,Weatherburn Pet al.Illicit drug use among men who have sex with men in England and Wales.Addict Res Theory. 2010;18:14-22.
10. Mattison AM,Ross MW,Wolfson Tet al.Circuit party attendance, club drug use, and unsafe sex in gay men.J Subst Abuse. 2001;13:119-126.
11. Vosburgh HW,Mansergh G,Sullivan PSet al.A review of the literature on event-level substance use and sexual risk behavior among men who have sex with men.AIDS Behav. 2012;16:1394-1410.
12. Drumright LN,Patterson TL,Strathdee SA.Club drugs as causal risk factors for HIV acquisition among men who have sex with men: a review.Subst Use Misuse. 2006;41:1551-1601.
13. Wohlfeiler D,Potterat JJ.Using gay men's sexual networks to reduce sexually transmitted disease (STD)/human immunodeficiency virus (HIV) transmission.Sex Transm Dis. 2005;32:S48-S52.
14. Singer M,Clair S.Syndemics and public health: reconceptualizing disease in bio-social context.Med Anthropol Q. 2003;17:423-441.
15. Bonell CP,Hickson FCI,Weatherburn Pet al.Methamphetamine use among gay men across the UK.Int J Drug Pol. 2010;21:244-246.
16. Shoptaw S,Frosch D.Substance abuse treatment as HIV prevention for men who have sex with men.AIDS Behav. 2000;4:193-203.
17. Butler AC,Chapman JE,Forman EMet al.The empirical status of cognitive-behavioral therapy: a review of meta-analyses.Clin Psychol Rev. 2006;26:17-31.
18. Beck A.The current state of cognitive therapy: a 40-year retrospective.Arch Gen Psychiatr. 2005;62:953-959.
19. Knapp W,Soares B,Farrell Met al.Psychosocial interventions for cocaine and psychostimulant amphetamines related disorders (Review).Cochrane Database Syst Rev. 2008; (3): Art. No.: CD003023-Art. No.: CD003023.
20. Statistics South Africa. Mid-year population estimates, 2010. Pretoria: Statistics South Africa, 2010.
21. Hogg RS,O'Shaughnessy MV,Gataric Net al.Decline in deaths from AIDS due to new antiretrovirals.Lancet. 1997;349:1294.
22. Granich RM,Gilks CF,Dye Cet al.Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model.Lancet. 2009;373:48-57.
23. Cohen MS,Chen YQ,McCauley Met al.Prevention of HIV-1 infection with early antiretroviral therapy.New Engl J Med. 2011;365:493-505.
24. Donnell D,Baeten JM,Kiarie Jet al.Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis.Lancet. 2010;375:2092-2098.
25. Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: recommendations for a public health approach, 2010 version. Geneva: World Health Organization, http://whqlibdoc.who.int/publications/2010/9789241599818_eng.pdf (2010, accessed 1 May 2013).
26. Chigwedere P,Seage GR,Gruskin Set al.Estimating the lost benefits of antiretroviral drug use in South Africa.J Acquir Immune Defic Syndr. 2008;49:410-415.
27. Karim SSA,Churchyard GJ,Karim QAet al.HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response.Lancet. 2009;374:921-933.
28. National Department of Health. Clinical guidelines for the management of HIV & AIDS in adults and adolescents. Pretoria: National Department of Health, Republic of South Africa, 2010.
29. Rapid advice: antiretroviral therapy for HIV infection in adults and adolescents. Geneva: World Health Organization; 2009:.
30. National Department of Health, Republic of South Africa. The South African antiretroviral treatment guidelines, 2013. Pretoria: National Department of Health, Republic of South Africa, 2013.
31. Klausner JD,Serenata C,O'Bra Het al.Scale-up and continuation of antiretroviral therapy in South African treatment programs, 2005-2009.J Acquir Immune Defic Syndr. 2011;56:292-295.
32. Jahn A,Floyd S,Crampin ACet al.Population-level effect of HIV on adult mortality and early evidence of reversal after introduction of antiretroviral therapy in Malawi.Lancet. 2008;371:1603-1611.
33. Egger M,Boulle A.Population effect of scaling up ART in resource-poor settings.Lancet. 2008;371:1558-1559.
34. Mid-year population estimates, 2011. Pretoria: Statistics South Africa; 2011:.
35. Garrett L.The challenge of global health.Foreign Affairs. 2007;86:14-38.
36. Shiffman J.Has donor prioritization of HIV/AIDS displaced aid for other health issues?.Health Pol Plan. 2008;23:95-100.
37. Day C,Gray ASouth African health review 2010. Fonn SPadarath A, ed. Durban: Health Systems; 2010:211-264.
38. Mortality and causes of death in South Africa, 2009: Findings from death notification. Pretoria: Statistics South Africa; 2011:.
39. Shisana O,Rehle T,Simbayi LCet al.South African national HIV prevalence, incidence, behaviour and communication survey 2008: A turning tide among teenagers?.Cape Town: HSRC,. 2009.
40. Mid-year population estimates, 2009. Pretoria: Statistics South Africa; 2009:.
41. Mid-year population estimates, 2006. Pretoria: Statistics South Africa; 2006:.
42. Mid-year population estimates, 2005. Pretoria: Statistics South Africa; 2005:.
43. Mid-year population estimates, 2007. Pretoria: Statistics South Africa; 2007:.
44. Mid-year population estimates, 2008. Pretoria: Statistics South Africa; 2008:.
45. Rajaratnam JK,Marcus JR,Levin-Rector Aet al.Worldwide mortality in men and women aged 15-59 years from 1970 to 2010: a systematic analysis.Lancet. 2010;375:1704-1720.
46. Doyle P and Dorrington R. Expansion of ARV programme in SA slows AIDS mortality rate. In: Actuarial Society of South Africa. Cape Town: Actuarial Society of South Africa, 2011.
47. Herbst AJ,Cooke GS,Barnighausen Tet al.Adult mortality and antiretroviral treatment roll-out in rural KwaZulu-Natal, South Africa.Bull World Health Organ. 2009;87:754-762.
48. Bor J,Herbst AJ,Newell MLet al.Increases in adult life expectancy in rural South Africa: valuing the scale-up of HIV treatment.Science. 2013;339:961-965.
49. Bendavid E,Bhattacharya J.The President's Emergency Plan for AIDS Relief in Africa: an evaluation of outcomes.Ann Intern Med. 2009;150:688-695.
50. Bendavid E,Holmes CB,Bhattacharya Jet al.HIV development assistance and adult mortality in Africa.JAMA. 2012;307:.
51. Cohen RL,Yuanzhang L,Giese Ret al.An evaluation of the President's Emergency Plan for AIDS Relief effect on health systems strengthening in sub-Saharan Africa.J Acquir Immune Defic Syndr. 2013;62:471-479.
52. Yudkin PL,Burger EH,Bradshaw Det al.Deaths caused by HIV disease under-reported in South Africa.AIDS. 2009;23:1600-1602.
53. Bradshaw D,Dorrington RE,Laubscher RRapid mortality surveillance report 2011. Cape Town: South African Medical Research Council; 2012:.